M&A Deal Summary

Aduro Biotech Acquires BioNovion Holding B.V.

On September 24, 2015, Aduro Biotech acquired life science company BioNovion Holding B.V. for 15M USD

Acquisition Highlights
  • This is Aduro Biotech’s 1st transaction in the Life Science sector.
  • This is Aduro Biotech’s largest (disclosed) transaction.
  • This is Aduro Biotech’s 1st transaction in the Netherlands.

M&A Deal Summary
Date 2015-09-24
Target BioNovion Holding B.V.
Sector Life Science
Buyer(s) Aduro Biotech
Deal Type Add-on Acquisition
Deal Value 15M USD

Target

BioNovion Holding B.V.

Oss, Netherlands
BioNovion Holding B.V. is a monoclonal antibody discovery and development company.

Search 200,197 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Aduro Biotech

Berkeley, California, United States
Category Company
Sector Life Science
Revenue 17M USD (2019)
DESCRIPTION

Aduro Biotech is a clinical-stage immunotherapy company focused on the discovery, development, and commercialization of therapies that transform the treatment of challenging diseases.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
Country (Netherlands) 1 of 1
Year (2015) 1 of 1
Size (of disclosed) 1 of 1
Mergr

Product

Company

Legal